Get in touch

Get in touch

Your enquiry will be sent to the relevant lead trial centre or sponsor. We need either an email address or phone number to enable the trial team to respond to your query.  Any form submitted without either of these cannot be processed.

A phase 2a study evaluating the safety and tolerability of a new mRNA therapy (RCT2100) in combination with ivacaftor in people with CF

Name
Nature of enquiry
I am

Information entered into this contact form will not be stored by the Cystic Fibrosis Trust

Your enquiry will be sent to the relevant lead trial centre or Sponsor